Trial to Evaluate the Impact of Various Interventions to Increase the Uptake of Surveillance Mammography in Eligible Women in Singapore
Pragmatic Randomized Trial to Evaluate the Impact of Various Interventions to Increase the Uptake of Surveillance Mammography in Eligible Women in Singapore
1 other identifier
interventional
12,000
1 country
1
Brief Summary
Breast cancer is the most common cancer among women in Singapore, with more than 70 women out of every 100,000 being diagnosed each year. Early detection through regular mammograms can significantly reduce deaths from breast cancer. Although Singapore has had a national breast cancer screening program (now part of the Screen for Life initiative) for over 20 years, and the government offers substantial subsidies to make screening more affordable, participation remains low at only 30-40%. This low uptake is due to factors like fear, lack of awareness, cultural beliefs, and a perceived low risk of breast cancer. To be effective on a large scale, at least 70% of women need to participate in regular mammography screenings. While researchers in Singapore and Asia have studied the reasons behind low screening rates, there is still a lack of large-scale studies that test different strategies to increase mammography participation in these regions. This trial will recruit 12,000 women aged 50-69 who have not undergone a mammogram in the past two years. 9000 women will be randomized into five intervention arms. The interventions include: direct mail reminder (Arm 1, control, n=3000), financial incentive (Arm 2, n=1500), lottery incentive (Arm 3, n=1500), health messaging from an influential figure (Arm 4, n=1500), and personal health concierge for appointment scheduling (Arm 5, n=1500). Another 3000 women will be placed in a non-interventional arm (NI arm) for observational analysis, that receives no reminders at all. A post-intervention telephone survey will assess intervention effectiveness. The primary outcome is mammogram uptake across intervention arms with Arm 1 as a reference. Secondary outcome will be to compare Arm 1 with NI arm. Subgroup analyses will evaluate differences in uptake by sociodemographic factors, such as ethnicity and socioeconomic status. A cost-effectiveness analysis will assess the financial viability of each intervention. This is the first large-scale study in Singapore and Asia to compare multiple interventions to boost mammography uptake. Findings will provide evidence-based strategies to improve breast cancer screening participation, potentially reducing breast cancer mortality and informing future public health policy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2024
CompletedFirst Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 22, 2025
October 1, 2024
4 months
December 10, 2024
May 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Mammogram Uptake Between Intervention Arms (2-5) and Control Arm
Primary endpoint: Comparison of the proportion of women who undergo surveillance mammography among participants in Arms 2-5 versus Arm 1 (control arm).
3 month from study start or 4 months from randomization
Study Arms (6)
Observational Arm
NO INTERVENTIONDoes not receive any mailer reminder to go for mammogram.
Arm 1 (control)
EXPERIMENTALReceives a mail reminder with basic information about breast cancer and instructions on scheduling a mammogram
Arm 2: Financial incentive
EXPERIMENTALReceives mail reminder + a $10 voucher for completing a mammogram within three months.
Arm 3: Lottery incentive
EXPERIMENTALReceives mail reminder + chance to win a $5000 lottery for completing the screening within three months.
Arm 4: Health messaging
EXPERIMENTALReceives mail reminder + QR code to a 60-second video from an influential person, available in four languages (English, Chinese, Malay, Tamil).
Arm 5: Personal Health Concierge
EXPERIMENTALReceives mail reminder + a dedicated hotline for scheduling mammograms with the help of a health concierge over eight weeks.
Interventions
Participants completing the mammogram within the study end date will receive a $10 voucher.
Participants completing the mammogram within the study end date will receive achance to win a $5000 lottery.
Participants will receive a less than 5 minute long video from an influential person. The video will be available in four languages (English, Chinese, Malay, Tamil).
Participants will be able to call a dedicated hotline for scheduling mammograms with the help of a health concierge over eight weeks of receive the the mailer.
Receives a mail reminder with basic information about breast cancer and instructions on scheduling a mammogram.
Eligibility Criteria
You may qualify if:
- Singaporean citizen
- Age 50-69
- Registered as a patient at the National University Hospital
- Registered and active user of OneNUHS App
- Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
You may not qualify if:
- Diagnosis of breast cancer in EPIC
- Mammogram done in the past 24 months in EPIC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, Singapore
Related Publications (1)
Lee SC, Lucky SS, Zhu J, Ow S, Loh L, Tan JH, Lim SE, Hairom Z, Mehta S, Tai BC, Goh BC. Pragmatic Interventions to Boost Surveillance Mammogram Uptake Among an Overdue Population: A Randomized Clinical Trial. JAMA Intern Med. 2026 Jan 1;186(1):27-35. doi: 10.1001/jamainternmed.2025.5873.
PMID: 41212556DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
September 16, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
May 22, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share